Evidence map›Paper›PMID 28965839›Full record

ArticleNeuroscience2017

DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1.

Jill C Fehrenbacher, Chunlu Guo, Mark R Kelley, Michael R Vasko

Abstract read
In one paragraph

Article in Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1α.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Biosynthesis inhibition of miR-142-5p in a NCellular & molecular biology letters · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Neuroimmune interplay in kidney health and disease: Role of renal nerves.Autonomic neuroscience : basic & clinical · 2023
    Review
  11. Article
  12. Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.The Journal of pharmacology and experimental therapeutics · 2023
    Review
  13. DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. APE1/Ref-1 as a Novel Target for Retinal Diseases.Journal of cellular signaling · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jill C FehrenbacherIndiana University School of Medicine, Department of Pharmacology and Toxicology, USA; Indiana University School of Medicine, Stark Neuroscience Research Institute, USA. Electronic address: jfehrenb@iu.edu.
Chunlu GuoIndiana University School of Medicine, Department of Pharmacology and Toxicology, USA. Electronic address: cguo@iupui.edu.
Mark R KelleyIndiana University School of Medicine, Department of Pharmacology and Toxicology, USA; Indiana University School of Medicine, Department of Pediatrics, Herman B Wells Center for Pediatric Research, USA. Electronic address: mkelley@iu.edu.
Michael R VaskoIndiana University School of Medicine, Department of Pharmacology and Toxicology, USA; Indiana University School of Medicine, Stark Neuroscience Research Institute, USA. Electronic address: vaskom@iupui.edu.
Indiana University – Purdue University Indianapolis · USNeurosciences Institute · US

Funding

(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathyR01CA205166 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI FEHRENBACHER, JILL C, KELLEY, MARK R. · 2017 to 2021
$2.7M
The Role of Ape1 in Neurotoxicity of Cancer TreatmentsR01CA121168 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI KELLEY, MARK R. · 2008 to 2012
$2.4M
Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancerR01CA138798 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI POLLOK, KAREN ELIZABETH · 2010 to 2014
$1.5M
DNA damage and repair in inflammation-induced peripheral sensitizationR21NS091667 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI FEHRENBACHER, JILL C, KELLEY, MARK R. · 2015 to 2016
$429k
NCI NIH HHS R01 CA121168NCI NIH HHS R01 CA138798NCI NIH HHS R01 CA205166NINDS NIH HHS R21 NS091667
6 · The paper itself

Abstract

Although inflammation-induced peripheral sensitization oftentimes resolves as an injury heals, this sensitization can be pathologically maintained and contribute to chronic inflammatory pain. Numerous inflammatory mediators increase the production of reactive oxygen (ROS) and nitrogen species (RNS) during inflammation and in animal models of chronic neuropathic pain. Our previous studies demonstrate that ROS/RNS and subsequent DNA damage mediate changes in neuronal sensitivity induced by anticancer drugs and by ionizing radiation in sensory neurons, thus we investigated whether inflammation and inflammatory mediators also could cause DNA damage in sensory neurons and whether that DNA damage alters neuronal sensitivity. DNA damage was assessed by pH2A.X expression and the release of the neuropeptide, calcitonin gene-related peptide (CGRP), was measured as an index of neuronal sensitivity. Peripheral inflammation or exposure of cultured sensory neurons to the inflammatory mediators, LPS and MCP-1, elicited DNA damage. Moreover, exposure of sensory neuronal cultures to LPS or MCP-1 resulted in changes in the stimulated release of CGRP, without altering resting release or CGRP content. Genetically enhancing the expression of the DNA repair enzyme, apurinic/apyrimidinic endonuclease (APE1) or treatment with a small-molecule modulator of APE1 DNA repair activity, both which enhance DNA repair, attenuated DNA damage and the changes in neuronal sensitivity elicited by LPS or MCP-1. In conclusion, our studies demonstrate that inflammation or exposure to inflammatory mediators elicits DNA damage in sensory neurons. By enhancing DNA repair, we demonstrate that this DNA damage mediates the alteration of neuronal function induced by inflammatory mediators in peptidergic sensory neurons.

Indexed as

DNA DamageAnimalsChemokine CCL2DNA-(Apurinic or Apyrimidinic Site) LyaseGanglia, SpinalHindlimbInflammationInflammation MediatorsLipopolysaccharidesMaleRats, Sprague-DawleySensory Receptor CellsApex1 protein, ratCcl2 protein, ratChemokine CCL2DNA-(Apurinic or Apyrimidinic Site) LyaseInflammation MediatorsLipopolysaccharidesapurinic/apyrimidinic endonuclease 1/redox effector factor 1DNA damagedorsal root gangliaE3330inflammationTRPV1

Identifiers

PMID28965839
PMCPMC5954980
OpenAlexW2758767181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.